The medicine shortage reports database includes information about shortages of reportable medicines in Australia, including those arising from the discontinuation of products.
You can use this page to search for all medicines in shortage and find information about management actions, including supply of overseas alternative medicines.
Information in this database is based on details reported to us by sponsors. Any additional management actions taken by us will be clearly stated.
How to search
The database defaults to all current medicine shortages. You can also view anticipated and resolved shortages and discontinuations.
To search the database for all shortages and discontinuations for a particular medicine, type the active ingredient or trade (brand) name into the search field. You can then click on the active ingredient name or trade name for more information about the shortage of interest.
You can also download an extract of all shortages and discontinuations.
To view all medicines shortages and discontinuations with a critical shortage impact rating, click on the CRITICAL medicine shortages link below.
Further information
Information about medicine shortages is available at the Medicine Shortages hub
Subscribe to Medicine Shortages updates
You can subscribe to Medicine Shortages Email Alerts or the Medicine Shortages RSS feed for frequently updated information.
This service does not support Internet Explorer 7 and below.
Search Results
Browse CRITICAL shortages and discontinuations
Click here to display ALL medicine shortages and discontinuations
AUST R: 14332
Expected supply: 31 Dec 2026
Availability: Unavailable
Management action: An unregistered product has been approved for supply under Section 19A. Please contact the approval holder for details on supply: Global Medical Solutions Australia Pty Limited T/A Radpharm Scientific - Ph: 02 9503 8100
Updated: 02-01-2024
phenoxybenzamine hydrochloride
AUST R: 12980
Expected supply: 30 Jun 2026
Availability: Unavailable
Management action: An unregistered product has been approved for supply under Section 19A. See the website: https://www.tga.gov.au/ws-sl9a-index and search for the active ingredient.
Updated: 28-07-2025
AUST R: 18695
Expected supply: 31 Jul 2026
Availability: Unavailable
Management action: An unregistered product has been approved for supply under Section 19A. See the website: https://www.tga.gov.au/ws-s19a-index and search for the active ingredient
Updated: 14-05-2025
AUST R: 32486
Expected supply: 31 Mar 2026
Availability: Unavailable
Management action: An unregistered product has been approved for supply under Section 19A. See the website: https://www.tga.gov.au/ws-s19a-index and search for the active ingredient.
Updated: 10-07-2025
Mycobacterium bovis (Bacillus Calmette and Guerin (BCG) strain)
ONCOTICE BCG 5 hundred million CFU powder for injection vial
AUST R: 59912
Expected supply: 31 Dec 2026
Availability: Limited Availability
Management action: An unregistered product has been approved for supply under Section 19A. See the website: https://www.tga.gov.au/ws-s19a-index and search for the active ingredient.
Updated: 18-07-2025
SYNACTHEN DEPOT tetracosactide (tetracosactrin) zinc complex 1mg/1m L injection ampoule
AUST R: 11060
Expected supply: 30 Nov 2026
Availability: Unavailable
Updated: 16-10-2025
TOFRANIL 25 imipramine hydrochloride 25mg tablet blister pack
AUST R: 60673
Expected supply: 31 Mar 2026
Availability: Unavailable
Management action: An overseas-registered product has been approved for supply under Section 19A. See the website and search for the active ingredient: www.tga.gov.au/resources/section-19a-approvals
Updated: 06-02-2026
AMIKACIN WOCKHARDT amikacin (as sulfate) 500mg/2mL solution for injection infusion vial
AUST R: 288798
Expected supply: 30 Apr 2026
Availability: Unavailable
Management action: Alternative brands are available.
Updated: 30-06-2025
VORICONAZOLE WOCKHARDT voriconazole 200 mg powder for injection vial
AUST R: 267013
Expected supply: 31 Dec 2026
Availability: Unavailable
Management action: Alternative brands are available.
Updated: 30-06-2025
ISOPRENALINE MACURE isoprenaline hydrochloride 1 mg/5 mL solution for injection ampoule
AUST R: 370377
Expected supply: Unknown
Availability: Unavailable
Management action: Alternative generic products are available.
Updated: 08-01-2026
HEPARINISED SALINE 50IU/5mL (porcine mucous) injection ampoule
AUST R: 66684
Expected supply: 30 Apr 2026
Availability: Unavailable
Management action: An unregistered product has been approved for supply under Section 19A. The approval holder, ORSPEC Pharma Pty Ltd, can be contacted for details on supply on 02 4339 4239.
Updated: 04-12-2025
OVIDREL choriogonadotropin alfa (rch) 250 microgram/ 0.5mL solution for injection pre-filled pen
AUST R: 170446
Expected supply: 30 Sep 2027
Availability: Limited Availability
Management action: The sponsor is closely controlling the supply. An unregistered product has been approved for supply under Section 19A. See the website: https://www.tga.gov.au/ws-sl9a-index and search for the active ingredient.
Updated: 23-12-2025
PEGASYS peginterferon alfa-2a 135 micrograms/0.5mL injection pre-filled syringe
AUST R: 91836
Expected supply: 30 Jun 2026
Availability: Unavailable
Management action: This medicine can be accessed through the Pegasys Home Delivery Program. For information on this program, go to https://www.echotherapeutics.com.au/echocarepegasyspatient. An unregistered product has also been approved for supply under Section 19A. The approval holder, Echo Therapeutics Pty Ltd, can be contacted for details on supply on 1300 848 328. The TGA have published a webpage with information about these shortages: https://www.tga.gov.au/safety/shortages/information-about-major-medicine-shortages/about-shortage-pegasys-peginterferon-alfa-2a-injection
Updated: 12-01-2026
PEGASYS peginterferon alfa-2a 180 micrograms/0.5mL injection pre-filled syringe
AUST R: 91837
Expected supply: 30 Jun 2026
Availability: Unavailable
Management action: This medicine can be accessed through the Pegasys Home Delivery Program. For information on this program, go to https://www.echotherapeutics.com.au/echocarepegasyspatient. An unregistered product has also been approved for supply under Section 19A. The approval holder, Echo Therapeutics Pty Ltd, can be contacted for details on supply on 1300 848 328. The TGA have published a webpage with information about these shortages: https://www.tga.gov.au/safety/shortages/information-about-major-medicine-shortages/about-shortage-pegasys-peginterferon-alfa-2a-injection
Updated: 12-01-2026
AUST R: 158452
Expected supply: 30 Jun 2026
Availability: Limited Availability
Management action: The sponsor continues to receive regular supply and is distributing supply carefully to equitably meet local demand. It is advised that patients continue to collect their prescription within their usual time frame and not to hold additional stock of the product. An updated TGA web statement is available at https://www.tga.gov.au/safety/shortages/information-about-major-medicine-shortages/about-shortage-creon-pancreatic-extract-capsules
Updated: 15-12-2025
AUST R: 313833
Expected supply: 30 Jun 2026
Availability: Limited Availability
Management action: The sponsor continues to receive regular supply and is distributing supply carefully to equitably meet local demand. It is advised that patients continue to collect their prescription within their usual time frame and not to hold additional stock of the product. An updated TGA web statement is available at https://www.tga.gov.au/safety/shortages/information-about-major-medicine-shortages/about-shortage-creon-pancreatic-extract-capsules
Updated: 15-12-2025
AUST R: 14328
Expected supply: 30 Jun 2026
Availability: Unavailable
Management action: An unregistered product has been approved for supply under Section 19A. The approval holder, Global Medical Solutions, can be contacted for details on supply on 02 9503 8100.
Updated: 18-12-2025
AUST R: 46942
Expected supply: Unknown
Availability: Reduction in supply until supply is exhausted
Management action: Overseas registered products have been approved for supply under Section 19A. See the website and search for the active ingredient: https://www.tga.gov.au/resources/section-19a-approvals
Updated: 28-11-2025
Pfizer (Australia) DAUNORUBICIN (as hydrochloride) 20mg/10mL injection vial
AUST R: 12723
Expected supply: Unknown
Availability: Reduction in supply until supply is exhausted
Management action: The product will be replaced by: PFIZER DAUNORUBICIN daunorubicin (as hydrochloride) 18.7 mg powder for injection vial ARTG 399600
Updated: 15-10-2024
AUST R: 14667
Expected supply: Unknown
Availability: Reduction in supply until supply is exhausted
Updated: 07-02-2025
APRESOLINE hydralazine hydrochloride 20mg powder for injection ampoule
AUST R: 43190
Expected supply: 31 Mar 2026
Availability: Unavailable
Management action: Unregistered products have been approved for supply under section 19A. See the website and search for the active ingredient: https://www.tga.gov.au/resources/section-19a-approvals
Updated: 19-12-2025
AUST R: 59743
Expected supply: Unknown
Availability: Reduction in supply until supply is exhausted
Management action: Patients are advised to consult their health professional to discuss alternative treatment options
Updated: 24-12-2024
AUST R: 337516
Expected supply: 29 May 2026
Availability: Unavailable
Management action: Alternative presentations are available
Updated: 12-11-2025
AUST R: 233443
Expected supply: 27 Feb 2026
Availability: Limited Availability
Management action: Overseas-registered products have been approved for supply under Section 19A. See the website and search for the active ingredient: https://www.tga.gov.au/resources/section-19a-approvals
Updated: 20-11-2025
DBL SULFAMETHOXAZOLE 400 mg and TRIMETHOPRIM 80 mg/5 mL concentrated injection ampoule
AUST R: 16293
Expected supply: 31 Jul 2026
Availability: Unavailable
Management action: An alternative brand is available.
Updated: 12-01-2026
benzathine benzylpenicillin tetrahydrate
AUST R: 147169
Expected supply: 31 Aug 2026
Availability: Limited Availability
Management action: The supply of Bicillin L-A 1.2 million unit prefilled syringe for injection has resumed, with supplies now available to order through wholesalers.
The TGA have published a web statement outlining key information about the shortage which is available at https://www.tga.gov.au/safety/shortages/information-about-major-medicine-shortages/about-shortage-bicillin-l-benzathine-benzylpenicillin-tetrahydrate-prefilled-syringe-injection
Updated: 29-01-2026
DBL BLEOMYCIN 15000IU (as sulfate) powder for injection vial
AUST R: 42569
Expected supply: 08 Dec 2025
Availability: Available
Updated: 08-12-2025
AUST R: 82503
Expected supply: Unknown
Availability: Reduction in supply until supply is exhausted
Management action: Alternative generic products are available
Updated: 17-11-2025
AUST R: 159342
Expected supply: Unknown
Availability: Reduction in supply until supply is exhausted
Management action: Reduction in supply until supply is exhausted.
Updated: 24-12-2025
AUST R: 159338
Expected supply: Unknown
Availability: Reduction in supply until supply is exhausted
Management action: Reduction in supply until supply is exhausted
Updated: 24-12-2025
AUST R: 115008
Expected supply: 01 Jan 2026
Availability: Available
Updated: 05-01-2026
AUST R: 356332
Expected supply: 08 Jan 2026
Availability: Available
Updated: 08-01-2026
phenoxymethylpenicillin potassium
ASPECILLIN VK phenoxymethylpenicillin 500mg (as potassium) tablet bottle
AUST R: 200137
Expected supply: 24 Nov 2025
Availability: Available
Updated: 25-11-2025
AUST R: 48231
Expected supply: 03 Dec 2025
Availability: Available
Updated: 04-12-2025
PHENYTOIN JUNO (phenytoin sodium) 100mg/ 2mL injection ampoule
AUST R: 117872
Expected supply: 31 Dec 2026
Availability: Unavailable
Management action: Overseas registered products have been approved for supply under Section 19A. See the website and search for the active ingredient: https://www.tga.gov.au/resources/section-19a-approvals
Updated: 04-12-2025
PHENYTOIN JUNO (phenytoin sodium) 250mg/ 5mL injection ampoule
AUST R: 117865
Expected supply: 31 Dec 2026
Availability: Unavailable
Management action: Overseas registered products have been approved for supply under Section 19A. See the website and search for the active ingredient: https://www.tga.gov.au/resources/section-19a-approvals
Updated: 04-12-2025
AUST R: 233442
Expected supply: 27 Feb 2026
Availability: Emergency Supply Only
Management action: Sponsor is closely controlling the supply.
Updated: 29-01-2026
tiagabine hydrochloride monohydrate
GABITRIL tiagabine (as hydrochloride monohydrate) 5mg tablet bottle
AUST R: 120271
Expected supply: Unknown
Availability: Reduction in supply until supply is exhausted
Management action: Patients are advised to consult their healthcare professional to discuss alternative treatment options.
Updated: 24-06-2025
tiagabine hydrochloride monohydrate
GABITRIL tiagabine (as hydrochloride monohydrate) 10mg tablet bottle
AUST R: 120272
Expected supply: Unknown
Availability: Reduction in supply until supply is exhausted
Management action: Patients are advised to consult their healthcare professional to discuss alternative treatment options.
Updated: 24-06-2025
tiagabine hydrochloride monohydrate
GABITRIL tiagabine (as hydrochloride monohydrate) 15mg tablet bottle
AUST R: 120273
Expected supply: Unknown
Availability: Reduction in supply until supply is exhausted
Management action: Patients are advised to consult their healthcare professional to discuss alternative treatment options.
Updated: 24-06-2025
TOPOTECAN ACCORD topotecan (as hydrochloride) 4 mg/4 mL concentrated injection vial
AUST R: 310761
Expected supply: 28 Feb 2026
Availability: Limited Availability
Management action: The sponsor is working to expedite the next shipment. An overseas-registered product has been approved for supply under Section 19A. See the website and search for the active ingredient: www.tga.gov.au/resources/section-19a-approvals
Updated: 06-01-2026
AUST R: 48230
Expected supply: 04 Dec 2025
Availability: Available
Updated: 04-12-2025
AUST R: 46943
Expected supply: 27 Mar 2026
Availability: Limited Availability
Management action: Overseas registered products have been approved for supply under Section 19A. See the website and search for the active ingredient: https://www.tga.gov.au/resources/section-19a-approvals
Updated: 28-11-2025
AUST R: 356333
Expected supply: 08 Jan 2026
Availability: Available
Updated: 08-01-2026
AUST R: 234750
Expected supply: 28 Feb 2026
Availability: Only available under NIP or government programs
Management action: The sponsor is working to expedite the next shipment.
Patients are advised to consult their healthcare professional to discuss treatment options.
Updated: 01-10-2025
EXARANE enoxaparin sodium 100mg/1mL solution for injection prefilled syringe
AUST R: 375491
Expected supply: Unknown
Availability: Reduction in supply until supply is exhausted
Management action: Other generic by same sponsor available – EXARANE enoxaparin sodium 100mg/1mL solution for injection prefilled syringe with safety lock system (ARTG 429091)
Updated: 03-02-2026
AUST R: 394103
Expected supply: 30 Apr 2026
Availability: Available
Management action: An overseas registered product has been approved for supply under Section 19A. The approval holder, Sanofi-Aventis Australia Pty Ltd, can be contacted for details on supply on 1800 818 806.
Updated: 27-01-2026
hydrocortisone hydrogen succinate
HYDROCORTISONE JUNO hydrocortisone (as sodium succinate) 100 mg powder for injection vial
AUST R: 377148
Expected supply: 14 Jan 2026
Availability: Available
Updated: 16-01-2026
IMUKIN interferon gamma-1b recombinant human 2 million IU (100 micrograms)/0.5mL injection vial
AUST R: 48404
Expected supply: Unknown
Availability: Unavailable
Updated: 30-01-2026
AUST R: 10113
Expected supply: 29 Jan 2026
Availability: Available
Updated: 29-01-2026
XELJANZ tofacitinib (as citrate) 1mg/mL oral solution bottle
AUST R: 386772
Expected supply: 29 Dec 2025
Availability: Available
Updated: 02-01-2026
ACTILYSE alteplase (rch) 10mg powder for injection vial with water for injections 10mL vial
AUST R: 64240
Expected supply: 04 Dec 2025
Availability: Available
Updated: 04-12-2025
ACTILYSE alteplase (rch) 50 mg powder for injection vial with diluent vial
AUST R: 17905
Expected supply: 20 Nov 2025
Availability: Available
Updated: 20-11-2025
TOFRANIL 10 imipramine hydrochloride 10mg tablet blister pack
AUST R: 11064
Expected supply: 09 Mar 2026
Availability: Available
Management action: Sponsor is working to expedite the next shipment.
Updated: 03-02-2026
AUST R: 73173
Expected supply: 11 Feb 2026
Availability: Limited Availability
Management action: The sponsor is closely controlling the supply.
Updated: 22-01-2026
AUST R: 79745
Expected supply: 25 May 2026
Availability: Available
Updated: 01-12-2025
AUST R: 47641
Expected supply: 17 Apr 2026
Availability: Available
Management action: The sponsor is closely controlling supply. An alternative brand is available.
Updated: 09-12-2025
dantrolene sodium hemiheptahydrate
DANTRIUM dantrolene sodium hemiheptahydrate 20mg powder for injection vial
AUST R: 14435
Expected supply: 29 Jan 2026
Availability: Available
Updated: 29-01-2026
PFIZER DAUNORUBICIN daunorubicin (as hydrochloride) 18.7 mg powder for injection vial
AUST R: 399600
Expected supply: 31 Mar 2026
Availability: Available
Management action: The sponsor is closely controlling the supply.Patients are advised to consult their healthcare professional to discuss alternative treatment options.
Updated: 03-02-2026
AUST R: 12063
Expected supply: Unknown
Availability: Reduction in supply until supply is exhausted
Management action: An alternative brand is available.
Updated: 24-12-2025
AUST R: 43100
Expected supply: 31 Mar 2026
Availability: Limited Availability
Management action: An overseas-registered product has been approved for supply under Section 19A. See the website and search for the active ingredient: www.tga.gov.au/resources/section-19a-approvals
Updated: 05-02-2026
AMPHOTERICIN LIPOSOMAL SUN amphotericin B (amphotericin) 50mg powder for injection vial
AUST R: 380963
Expected supply: 13 Jan 2026
Availability: Available
Updated: 16-01-2026
AUST R: 205168
Expected supply: 30 Jul 2026
Availability: Emergency Supply Only
Management action: An overseas-registered product has been approved for supply under Section 19A. See the website and search for the active ingredient: www.tga.gov.au/resources/section-19a-approvals
Updated: 24-12-2025
AUST R: 13455
Expected supply: 04 Feb 2026
Availability: Available
Updated: 04-02-2026
AUST R: 100517
Expected supply: 30 Jun 2026
Availability: Limited Availability
Management action: Sponsor is closely controlling the supply.
Updated: 21-01-2026
VANCOMYCIN JUNO vancomycin (as hydrochloride) 1 g powder for injection vial
AUST R: 407964
Expected supply: 08 May 2026
Availability: Available
Management action: Sponsor is working to expedite next shipment. An alternative brand is available.
Updated: 03-02-2026
IBIMICYN ampicillin 500mg (as sodium) powder for injection vial
AUST R: 92839
Expected supply: 26 Jun 2026
Availability: Available
Management action: Sponsor is working to expedite next shipment. Other strengths are available.
Updated: 04-02-2026
{{headingLabels[selectedTab]}}
Sort by: Updated date | Active ingredient | Trade name | Therapeutic class
URL: http://apps.tga.gov.au/prod/MSI/search/